AIDA
Healthcare Drug Manufacturers - Specialty & GenericAida Pharmaceuticals, Inc.
$0.00
+0.00 +0.00% today
Price History
Not enough data
Key Stats
Market Cap
12.56M
Avg Volume
0
52W High
$0.00
52W Low
$0.00
Div. Yield
0.0%
Valuation
P/B Ratio
0.00
P/S Ratio
0.31
EV/EBITDA
4.32
EV/Revenue
1.01
Margins
Gross Margin 55.1%
Operating Margin 21.3%
Net Margin (5.4%)
EBITDA Margin 23.5%
Growth & Returns
Revenue Growth (YoY)
61.2%
Earnings Growth (YoY)
341.1%
Earnings Growth (QoQ)
341.1%
Return on Equity
(1.8%)
Return on Assets
6.6%
Liquidity & Leverage
Current Ratio
0.73
Quick Ratio
0.46
Debt / Equity
2.37
Total Cash
8.28M
Total Debt
41.17M
About
Aida Pharmaceuticals, Inc., together with its subsidiaries, engages in the formulation, clinical testing, registration, manufacture, sales, and marketing of pharmaceutical and genetic products in mainland China. It offers antibiotics, cardiovascular, and anti-cancer drugs. The company provides its products in the form of powder for injection; and liquid for intravenous injection, capsule, tablet, and ointment. The company provides Etimicin Sulfate, an injectable powder form, as well as rh-Apo2l, a biopharmaceutical therapy for cancers. Aida Pharmaceuticals, Inc. was founded in 1999 and is headquartered in Hangzhou, China.